Company intelligence / Profile preview

NREP

Ownership: Private
Development stage: Commercial

Overview

NREP is a Nordic real estate investor and sustainability-focused venture capital firm. It recently launched "2150," a dedicated tech venture to invest in urban sustainability technologies, with an emphasis on reducing CO2 emissions and improving the built environment. The company is not involved in life sciences, biotech, pharma, or healthcare product development[3].

Industry: Investors

Partnerships

Chr. Augustinus Fabrikker (investor in 2150)Novo Holdings (investor in 2150)Vaekstfonden / Denmark’s Green Future Fund (investor in 2150)

Beyond the preview

Go deeper on NREP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NREP.

Explore the full profile